Skip to main content
. 2023 Mar 31;13(4):611. doi: 10.3390/jpm13040611

Table 1.

Patient characteristics.

First Admission Follow up at Last Contact, #, &
Gender Age LVEDD (z-Score) EF
(%)
BNP
(pg/mL)
Age LVEDD (z-Score) EF
(%)
BNP (pg/mL)
A.III.3 female 2 y +7.2 severely reduced 6528 # at the age of 2 y # # #
A.III.2 male 0 m +2.2 normal 206 # at the age of 13 y # # #
A.III.1 male 6 m −0.9 64 n.a. 5 y +3.9 66 n.a.
B. II.3 male n.a. n.a. n.a. n.a. & at the age 50 y & & &
B.III.3 male 5 m +8.4 reduced n.a. # at the age of 8 m,
& at the age of 12 y
& & &
B.III.4 male 12 y 7.7 severely reduced n.a. & at the age 12 y & & &
B.III.5 female 10 y 1.5 mildly reduced n.a. # at the age of 14 y, & at the age of 20 y & & &
B.III.6 male 21 m −0.4 normal n.a. 12 y +1.0 51 <50
C.II.1 female 4 y +4.6 25 3651 12 y +4.6 48 59
C.II.2 female 14 y +5.1 62 n.a. 16 y +4.8 48 29
C.I.2 female 35 y n.a. n.a. n.a. 39 y +5.2 n.a. n.a.

EF—ejection fraction; LVEDD—left ventricular end diastolic diameter; m—months; y—years. #—patient was heart transplanted, &—patient died.